Your browser doesn't support javascript.
loading
NFAT signaling dysregulation in cancer: Emerging roles in cancer stem cells.
Lin, Yibin; Song, Yifu; Zhang, Yaochuan; Shi, Mengwu; Hou, Ana; Han, Sheng.
Afiliação
  • Lin Y; Department of Neurosurgery, The First Hospital of China Medical University, Shenyang 110001, China.
  • Song Y; Department of Neurosurgery, The First Hospital of China Medical University, Shenyang 110001, China.
  • Zhang Y; Department of Neurosurgery, The First Hospital of China Medical University, Shenyang 110001, China.
  • Shi M; Department of Neurosurgery, The First Hospital of China Medical University, Shenyang 110001, China.
  • Hou A; Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang 110001, China. Electronic address: sunnyhou_815@126.com.
  • Han S; Department of Neurosurgery, The First Hospital of China Medical University, Shenyang 110001, China. Electronic address: hansheng2001_x@aliyun.com.
Biomed Pharmacother ; 165: 115167, 2023 Sep.
Article em En | MEDLINE | ID: mdl-37454598
ABSTRACT
The nuclear factor of activated T cells (NFAT) was first identified as a transcriptional regulator of activated T cells. The NFAT family is involved in the development of tumors. Furthermore, recent evidence reveals that NFAT proteins regulate the development of inflammatory and immune responses. New discoveries have also been made about the mechanisms by which NFAT regulates cancer progression through cancer stem cells (CSC). Here, we discuss the role of the NFAT family in the immune system and various cancer types.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição NFATC / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição NFATC / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article